Thomas Winkler is an Associate Professor at the Division of Micro and Nanosystems, KTH Royal Institute of Technology, Sweden, and collaborates with TU Braunschweig, Germany. His research focuses on solving life science challenges using microsystems tools, particularly in neuropsychiatric disorders like schizophrenia. He develops organ-on-chip models, engineered microfluidic platforms, and biosensors for point-of-care diagnostics. Winkler leads an interdisciplinary ERC-funded team addressing metabolic coupling in neurovascular units and oxidative stress biomarkers. Key achievements include the ERC Starting Grant (2023) and work on electrochemical sensors for clozapine monitoring. He teaches courses such as Microsystem Technology (EK2350) and supervises PhD and postdoctoral researchers. Current projects include machine learning-guided robotic organoid maturation and electrochemical technology development for the CHIPzophrenia initiative. His lab actively seeks talent through open positions in Stockholm and Braunschweig. Scientific awards include the ERC Starting Grant and Marie Skłodowska-Curie Actions Fellowship. Research spans sensor development, microfabrication, and biomaterials, with a focus on translating lab technologies to clinical applications. Collaborations bridge engineering and life sciences, emphasizing personalized mental healthcare solutions.
Dr. Carla Vilela is an Assistant Professor in the Department of Chemistry at the University of Aveiro and Principal Researcher at CICECO. She coordinates the Sustainable Materials research line and leads projects on cellulose-based materials and circular economy. Her research focuses on sustainable materials from cellulose and renewable resources for applications in water remediation, food packaging, and textiles. Education includes a PhD in Chemistry from the University of Aveiro and postdoctoral work at CICECO and ISIS Neutron and Muon Source (UK). Research interests include: Development of cellulose-based functional materials Nanocomposites for biomedical applications Sustainable packaging solutions Biopolymer modification and characterization Publications demonstrate strong focus on cellulose nanocomposites, bioprinting bioinks, and active packaging. Recent articles frequently involve nanocellulose modifications, drug delivery systems, and sustainable material design. Awards include being named among World's Top 2% Scientists annually since 2020. Funding includes national projects (Cell4Janus) and EU collaborations (PRIMA Im-Pack). Leads the BioPol4Fun research group and supervises 6 PhD students. Current projects explore cellulose-based microrobots, resin valorization, and marine biopolymers.
Associate Professor Arnold Lining Ju is a biomedical engineer at the University of Sydney's School of Biomedical Engineering, affiliated with multiple institutes including the Heart Research Institute and Sydney Nano Institute. He holds academic positions in both the Faculty of Engineering and Faculty of Medicine & Health. Education: BSc from Peking University, PhD from Georgia Tech and Emory University (USA). Honors include Snow Fellowship, Heart Foundation Future Leader Fellowship, and multiple awards for cardiovascular research innovation. Research focuses on mechanobiology and biomechanics of thrombosis, developing microfluidic devices and organ-on-chip systems. Key projects include AI-driven single-cell nanotools, 3D biofabrication, and anti-thrombotic peptide design. Leads interdisciplinary teams and collaborates internationally with institutions like Harvard and University of Texas. Teaching roles include coordinating advanced cellular biomechanics courses and supervising PhD/Masters students in biomedical engineering and physiology. Over 50 peer-reviewed publications, with contributions to Nature Materials, Nature Communications, and other top journals.
Steven Siciliano is a Professor and NSERC/FCL Industrial Research Chair in In Situ Remediation and Risk Assessment at the University of Saskatchewan's College of Agriculture and Bioresources. He leads the CREATE Human and Ecological Risk Assessment Program. His expertise spans soil toxicology, greenhouse gas dynamics in polar ecosystems, and nitrogen cycle interactions in contaminated environments. Education: Ph.D. in Toxicology, University of Saskatchewan B.Sc. in Biochemistry, Concordia University Research Interests: His work focuses on human-soil interaction dynamics, including soil pollution impacts on human health (e.g., PAH toxicity via soil ingestion) and ecosystem resilience (e.g., nitrogen cycle disruptions). He investigates Arctic/Antarctic soil microbiology, greenhouse gas production in polar deserts, and the ecological effects of pollutants like mercury and petroleum hydrocarbons. His lab is divided into toxicology (e.g., metal cardiovascular effects, soil ingestion models) and ecology (e.g., sub-zero water effects on gene expression, Arctic nitrogen cycles). Teaching: Teaches courses on environmental fate analysis, contaminated site management, and advanced risk assessment methodologies at both undergraduate and graduate levels. Courses include EVSC 420, TOX 820, and EVSC 821. Grants & Labs: Directs the CREATE Program and leads projects funded by NSERC and industry partnerships. His lab integrates fieldwork, molecular techniques, and modeling to address environmental remediation challenges. Collaborates on projects like cryoturbation-driven carbon dynamics and microbial community analysis in agricultural systems. Labs/Teams: Active in soil science research teams, including Arctic soil microbiology and bioremediation innovation groups. Engages in interdisciplinary collaborations with environmental engineers and ecologists to advance in situ remediation technologies.
Tiffany M Jamann is an Associate Professor in Crop Sciences at the University of Illinois, where she holds the Monsanto Fellowship in Plant Breeding. Her research program focuses on understanding and improving disease resistance mechanisms in maize through integrated genetic, genomic, and phenotypic approaches. Dr. Jamann's work spans multiple disease systems with particular emphasis on foliar diseases such as Northern Leaf Blight and ear diseases like Gibberella ear rot. Her research interests include: Quantitative trait locus (QTL) mapping for disease resistance in maize Development of near-isogenic line populations for gene discovery Comparative studies of resistance mechanisms across different pathosystems Investigation of pattern-triggered immunity in maize Standardization of pathogen inoculation and disease rating methodologies Analysis of Dr. Jamann's recent publications (2023-2025) reveals a strategic integration of traditional plant breeding with cutting-edge genomic approaches. Her work demonstrates increasing use of comparative genomics and transcriptomics to identify host-specificity genes in pathogens while maintaining strong focus on practical breeding applications. A notable trend is her development of standardized methodologies for pathogen inoculation across multiple disease systems, enabling more reliable resistance evaluation. Monsanto Fellow in Plant Breeding Multiple publications featured in news outlets and academic discussions Active research with significant social media engagement (46 X users mentioning her work) Dr. Jamann's research program likely involves extensive collaboration with other plant pathologists and breeders, as evidenced by her numerous co-authored publications. Her work on multi-environment trials suggests substantial field research across different geographical locations. The development of specialized maize germplasm, including near-isogenic lines, indicates long-term investment in genetic resources for disease resistance research. Her laboratory maintains sophisticated capabilities for pathogen characterization, high-throughput phenotyping using fluorescence microscopy, and genetic mapping approaches. The emphasis on both fundamental plant-pathogen interactions and applied crop improvement demonstrates a research program that bridges basic science with practical agricultural outcomes.
James M. Piret is a Professor at the University of British Columbia (UBC), affiliated with the School of Biomedical Engineering and the Michael Smith Laboratories. He holds a Sc.D. from MIT (1989), an S.M. from MIT (1986), and an A.B. from Harvard College (1981). His research focuses on bioprocessing, biomedical engineering, and cell therapy biotechnology, with emphasis on optimizing therapeutic cell production and biomanufacturing processes. Education : Sc.D. in Chemical Engineering, Massachusetts Institute of Technology (1989) S.M. in Chemical Engineering, Massachusetts Institute of Technology (1986) A.B. in Chemistry, Harvard College (1981) Professor Piret’s research integrates bioreactor engineering, Raman spectroscopy, and data analytics to advance cell-based therapies for diseases like cancer and diabetes. Collaborations with stem cell biologists (e.g., Drs. Kieffer and Levings) and engineers (Drs. Turner and Gopaluni) drive innovations in bioprocess optimization and device development. His lab emphasizes multidisciplinary approaches to accelerate biotechnology production processes and cell therapy manufacturing. Awards : William F. Meggers Award (2022) R.S. Jane Memorial Award (2015) Cell Culture Engineering Award (2012) Fellow, Chemical Institute of Canada (2004) His work includes developing novel methodologies for CHO cell glycosylation engineering, optimizing fed-batch bioreactor systems, and advancing Raman spectroscopy techniques for real-time cell analysis. The lab actively recruits motivated graduate and postdoctoral researchers to tackle high-impact challenges in biomedical and chemical engineering.
Melinda Yates, PhD, serves as Associate Professor in the Department of Pathology and Laboratory Medicine at the UNC School of Medicine, University of North Carolina at Chapel Hill. She is a UNC Lineberger Comprehensive Cancer Center member and holds leadership roles including Program Director for the Graduate Certificate in Women’s Health, Research Associate Director for the Graduate Program in Translational Medicine, and Faculty Advisor for the Women’s Health Multidisciplinary Consortium. Her research focuses on endometrial cancer—an understudied disease with rising incidence and mortality—investigating earliest molecular changes during cancer development related to obesity and hereditary DNA mismatch repair defects (Lynch syndrome). The Yates lab employs preclinical tools including rodent models, organoids, novel cell lines, and spatial biology platforms to study endometrial premalignancy in clinical specimens. Their work aims to define mechanisms by which environmental factors (obesity, hormones, social determinants of health) influence cancer development and disparities. Dr. Yates' research program ultimately targets cancer interception through pharmacologic agents to prevent, block, or reverse endometrial cancer development and improve women's health outcomes. Key focus areas include molecular therapeutics for cancer prevention and translational applications of spatial biology. Her notable recognitions include: President’s Faculty Excellence Award in Cancer Prevention or Outreach (MD Anderson Cancer Center, 2022) Faculty Recognition Award (UT MD Anderson/UTHealth Graduate School, 2022) Faculty Educator of the Quarter (UT MD Anderson Cancer Center, 2020) Faculty Recognition Award (UT MD Anderson/UTHealth Graduate School, 2019) As Program Director for the Graduate Certificate in Women’s Health and Research Associate Director for the Translational Medicine Graduate Program, she shapes educational initiatives while leading the Women’s Health Multidisciplinary Consortium to advance interdisciplinary collaboration. Her lab maintains extensive preclinical resources including specialized rodent models and organoid systems for endometrial cancer research.
Ruben Portugues is a Professor of Brain Circuit Function and Dysfunction at the Institute of Neuroscience, Technical University of Munich (TUM). He is a full member of the Graduate School of Systemic Neurosciences (GSN), an associate and advisory board member of the Munich Center for Neurosciences (MCN), and leads a research group focused on understanding the neural basis of behavior. His lab uses larval zebrafish as a model organism to investigate sensorimotor control, decision-making, and motor learning through whole-brain imaging and circuit analysis. His research interests lie at the intersection of systems neuroscience and behavior. He investigates how brain circuits process sensory information, integrate it with motor output, and enable adaptive and flexible behavior. Key areas include the function of the cerebellum, heading direction networks, sensorimotor transformations, and the neural mechanisms of decision-making. His lab employs cutting-edge techniques including custom-built microscopes, behavioral assays, and computational analysis. The recent publications and preprints from his lab demonstrate a strong trend in decoding distributed neural circuits underlying navigation and decision-making in zebrafish. There is a clear focus on identifying specific brain regions (e.g., interpeduncular nucleus, cerebellum) and cell types involved in processing visual, motor, and spatial information. The work increasingly emphasizes whole-brain functional imaging and the emergence of cognitive-like representations such as allocentric heading direction. FENS-Kavli Network of Excellence (FKNE) PhD Thesis Prize (awarded to student Luigi Petrucco) Ruben Portugues actively mentors PhD students, including current advisees Luigi Petrucco, Ot Prat, and Shuhong Huang, and has successfully graduated Dr. Elena Dragomir and Dr. Vilim Štih. His lab engages in extensive collaborations, hosts visiting researchers, participates in teaching (e.g., CSHL Imaging Course, Cajal Course), and secures resources for advanced research. The lab is known for building its own microscopes and software, fostering technical innovation. The Portugues Lab operates as a dynamic, interdisciplinary team that combines experimental neuroscience with computational and engineering approaches. They regularly hold retreats, participate in scientific events, and contribute to community initiatives like the Munich Brain Day. The lab is preparing to relocate to the Department of Neurobiology and Behavior at Cornell University, marking a new phase in its research trajectory.
Tyler Johnson, PhD, is an Associate Professor in the Department of Natural Sciences and Mathematics at Dominican University of California's School of Health and Natural Sciences. His expertise lies in Natural Products Chemistry , Bioorganic Chemistry , and Medicinal Chemistry , with a focus on biomedical applications. Johnson's research emphasizes discovering therapeutic lead compounds and molecular probes from marine and terrestrial natural products. His research team investigates chemotypes like mycothiazole , zampanolide , fijianolide , and latrunculin from Indo-Pacific marine sponges. These compounds exhibit potent cytotoxicity (IC50 1~5 nM) against cancer cell lines through mechanisms including microfilament disruption , mitochondrial complex I inhibition , and microtubule stabilization . Current work explores mycothiazole as a molecular probe for mitochondrial aging. Key publications span 2024-2002, covering topics from sponge-derived anticancer agents to inflammation modulation and environmental toxicology. Johnson's laboratory engages in large-scale natural product isolation, spectroscopic validation, and semi-synthetic medicinal chemistry to optimize therapeutic leads. His work integrates undergraduate and graduate students into interdisciplinary biomedical research.
Bertan Bakkaloglu is the On Semiconductor Professor in the School of Electrical, Computer and Energy Engineering at Arizona State University (ASU), where he has been since 2004. Prior to ASU, he worked at Texas Instruments focusing on analog, mixed-signal, and RF SoC development for communication transceivers. His research expertise spans RF and mixed-signal IC design, wireless/wireline communication systems, and broadband communication systems. Education: Ph.D. in Electrical Engineering, Oregon State University (1995) M.S.C. in Electrical Engineering, University of Houston (1992) Research Interests: RF and mixed-signal integrated circuits Power management ICs (including LDO regulators and DC-DC converters) High-efficiency power delivery systems Radiation-hardened electronics for space applications MEMS-based sensor systems Biomedical circuits for implantable devices Grants & Collaborations: Over 40+ funded research projects with institutions like NASA/JPL, BAE Systems, and NSF, focusing on power electronics, space systems, and biomedical applications Key projects include radiation-hardened converters, self-calibrating DACs, and implantable medical device circuits Industry partnerships with Texas Instruments, Space Micro, and FLIR Professional Activities: Technical committee member for IEEE Radio Frequency Integrated Circuits Conference Founding chair of IEEE Solid-State Circuits Society Phoenix Chapter
Dr. Lucy Gloag is a Lecturer at the Research School of Chemistry at the Australian National University (ANU), where she joined in 2024 after previously serving as a Lecturer at the University of Technology Sydney in 2023. Her research focuses on the development of advanced nanomaterials for energy applications, particularly in electrocatalysis and energy storage. Education: BSc/BCA and BSc(Hons) from Victoria University of Wellington, New Zealand PhD from the University of New South Wales (2018) on synthesis and characterization of Ru-based nanocatalysts Dr. Gloag is a nanomaterials chemist and electron microscopist specializing in the synthesis and characterization of nanomaterials for electrocatalytic applications. Her research addresses the fundamental question of how nanostructure can be used to enhance the performance of electrocatalysts . She employs solution-phase synthesis techniques to create nanoparticles with precise control over crystal structure, dimensions, and surface faceting, then correlates these structural features with electrocatalytic properties using transmission electron microscopy and electrochemistry. Her work spans energy conversion technologies, biomedical applications of nanoparticles, and advanced materials characterization. Analysis of her recent publications reveals a strong focus on single-atom catalysts, hierarchical nanostructures, and the relationship between nanomaterial structure and function. Her research spans both fundamental materials science and practical applications in energy conversion, with significant work on oxygen evolution reaction, hydrogen evolution reaction, and methanol oxidation electrocatalysts. She has also made notable contributions to biomedical applications of nanoparticles, particularly in magnetic particle imaging and Alzheimer's disease diagnostics. Scientific Awards: ARC Discovery Project Grant (2023) ARC Linkage Project Grant (2023) UNSW Science COVID19 Strategic Support Grant (October 2021) Dementia Australia Research Foundation – Yulgilbar Innovation Grant (2019-2022) Australian Postgraduate Research Scholarship (2015) AMN-7 Image Competition Finalist (2015) Dr. Gloag currently leads the ANU Futures Scheme 2.0 project (2024-2028) and has secured multiple competitive research grants, demonstrating strong research leadership. Her work involves extensive collaboration with researchers at UNSW and other institutions, particularly with Professors Richard Tilley and Justin Gooding. She has published 28 research outputs since 2015, with significant citation impact (h-index of 17). Her laboratory at ANU (Building 137, room 2.49) focuses on developing single atom and nanomaterials for energy storage and conversion technologies, continuing her trajectory as an emerging leader in advanced materials synthesis and electron microscopy characterization.
Sarah L. Keller is a Professor of Chemistry at the University of Washington, holding the Duane and Barbara LaViolette Endowed Chair. She earned her Ph.D. in Physics from Princeton University and completed postdoctoral research at UC Santa Barbara and Stanford University. Her research focuses on self-assembling soft matter systems, particularly lipid membrane biophysics and prebiotic chemistry. She investigates how lipid mixtures form complex phases and their biological implications. Education: Ph.D. in Physics, Princeton University (1995); postdoctoral training at UC Santa Barbara (Presidential Fellow) and Stanford University (NIH NRSA Fellow). Research Interests: Keller's lab explores phase behavior in lipid membranes, prebiotic vesicle formation, and membrane-driven cellular processes. They employ interdisciplinary approaches combining physics, chemistry, and bioengineering to study systems like yeast vacuoles and protocell models. Awards: Biophysical Society Avanti Award, Cottrell Scholar, NSF CAREER Award, Fellow of the American Physical Society, and recognition for mentoring and teaching excellence. Her students frequently win NSF Graduate Fellowships and international awards. Advising & Grants: Keller has mentored over 50 students/postdocs, many of whom hold academic or industry roles. Her lab emphasizes interdisciplinary collaboration, with funding from NSF, NIH, and private foundations. The Keller Lab also supports career development resources for early-career researchers. Labs/Teams: The lab is part of the UW Chemistry Department and collaborates with the UW Biophysics program. Research is conducted in the Bagley Hall laboratory, with access to advanced microscopy and simulation tools.
Prashant Mali is a Professor in the Department of Bioengineering at the University of California, San Diego . His research bridges genome engineering, RNA biology, and biomedical applications, with a focus on CRISPR-Cas systems and ADAR-mediated RNA editing. Education : Ph.D. in Bioengineering Key Affiliations : UC San Diego, Altman Clinical and Translational Research Institute Dr. Mali's work centers on CRISPR-Cas9 technology , RNA editing , and human pluripotent stem cells . His lab develops tools for programmable gene regulation, synthetic lethal screens, and metabolic pathway analysis in disease contexts. Recent publications highlight innovations in circular RNA engineering , ADAR activity mapping , and metabolic reprogramming in cancer . His team employs multi-omics approaches and in vivo models to translate genome editing into clinical applications. Students and Collaborators Current Lab Members : Sami Nourreddine (Postdoc), Amir Dailamy (Graduate), Andrew Portell (Graduate), Michael Tong (Graduate) Alumni : Kyle Ford (PhD 2022), Nathan Palmer (PhD 2022), Udit Parekh (PhD 2021) Research Themes CRISPR Screens : Synthetic lethal interactions, oncogenic pathways, metabolic vulnerabilities RNA Editing : ADAR engineering, circular guide RNAs, clinical translation Tissue Engineering : Vascularized organoids, cardiac maturation, ex vivo models
Dr. Philippe Campeau is an Associate Clinical Professor in the Department of Pediatrics at the Faculty of Medicine, Université de Montréal. He is affiliated with CHU Sainte-Justine, a major pediatric hospital in Montreal, Quebec, where he works in the Medical Genetics Service. His clinical and research work focuses on genetic disorders affecting children, particularly in the areas of skeletal development and neurogenetics. Dr. Campeau obtained his Doctorate in Medicine from Laval University in Quebec (1998-2003) followed by specialty training in medical genetics at McGill University (2003-2008). He completed postdoctoral training at Baylor College of Medicine (2008-2013), which further developed his expertise in genetic research methodologies. His primary research interests include bone dysplasias , skeletal dysplasias , epilepsy , and epigenetic diseases . Dr. Campeau's laboratory identifies disease-causing genes, deciphers disease pathophysiology, and works to improve the management of children affected by these conditions. His work encompasses exome analysis , functional studies with cell lines and mouse models , and investigations into urea cycle abnormalities . He has made significant contributions to understanding genetic causes of conditions such as Genitopatellar syndrome (KAT6B), osteopetrosis, dysosteosclerosis (SLC29A3), osteogenesis imperfecta, early-onset osteoporosis (WNT1), Yunis-Varón syndrome (FIG4), and DOORS syndrome (TBC1D24). Dr. Campeau's publication record demonstrates a strong trajectory in medical genetics research, with numerous high-impact publications spanning from fundamental genetic discovery to translational research. His work spans skeletal disorders, neurodevelopmental conditions, and epigenetic mechanisms. Recent publications indicate an expanding focus on chromatin modifiers, DNA methylation patterns, and spliceosome function in neurodevelopmental conditions, reflecting the evolution of his research interests toward more complex molecular mechanisms. Dr. Campeau has received several research grants in recent years (6 starting in 2014) from organizations including the Fonds de la recherche en santé du Québec, Canadian Institutes of Health Research, and Fondation Grand Défi Pierre Lavoie. While specific students are not mentioned in the available information, as a clinical professor, he mentors medical students, residents, and research trainees in the Department of Pediatrics. His research is conducted as part of the 'Musculoskeletal Diseases and Rehabilitation' axis at CHU Sainte-Justine Research Center, where he collaborates with international research teams to identify disease-causing genes and develop better management strategies for children with genetic disorders.
Mahipal Singh is a Professor of Animal Biotechnology and Coordinator of the Animal Science Undergraduate Program at Fort Valley State University (FVSU), where he is affiliated with the College of Agriculture, Family Sciences and Technology and the Department of Agricultural Sciences. He has been at FVSU since 2000 in various capacities, progressing from Adjunct Biology/MPH Graduate Faculty to his current position as full Professor since 2019. Dr. Singh earned his educational credentials in India: a B.S. (Hons) in Zoology from Meerut College (1978), an M.S. in Zoology from the Institute of Advanced Studies, Meerut University (1983), and a Ph.D. in Zoology-Microbiology from Banaras Hindu University, Varanasi (1989). His academic journey included prestigious appointments such as International Visiting Fellow at the National Institute of Child Health and Human Development, NIH (1991-1993) and Postdoctoral Fellow at the Medical University of South Carolina (1989-1991). His research focuses on cutting-edge areas of animal biotechnology, particularly in postmortem cell recovery, genome editing in livestock, and myostatin gene targeting. Dr. Singh has pioneered work demonstrating that individual cells remain viable in mammalian tissues for much longer periods after death than previously believed, with applications for cellular therapies and germplasm preservation. His work with CRISPR/Cas technology aims to reduce milk allergens and mastitis in goats, while his myostatin research seeks to enhance muscular mass in meat goats for agricultural applications. Analysis of his recent publications reveals a consistent focus on cellular viability after death across multiple livestock species (cattle, goats, sheep), with particular attention to temperature effects and storage conditions. His work bridges basic cellular biology with practical agricultural applications, demonstrating how fundamental discoveries about postmortem cellular life can translate into biotechnological advances for livestock preservation and improvement. USDA-ARS 1890 Faculty Research Fellowship Award (2017) STEM Research Excellence Award, Fort Valley State University (2014-15) Multiple student research presentation awards at FVSU Annual Research Day symposiums Best Poster Award at National Symposium on Biotechnology, CIMAP, Lucknow, India (1999) Fogarty International Visiting Fellowship at NIH (1991-93) Dr. Singh has supervised an impressive 38 students across multiple educational levels, including 4 PhD, 13 MS, 7 BS, 8 HS, and 6 middle school students. His research has been supported by USDA-ARS, USDA-NIFA programs, and various other grants. He serves on multiple editorial boards, grant review panels, and university committees, and is an active member of professional societies including the American Society of Animal Science and Society for In Vitro Biology. Based in the Stallworth Biotechnology Building at FVSU, Dr. Singh leads research projects that bridge molecular biology with practical agricultural applications, working collaboratively with researchers from USDA-ARS, University of Illinois, University of Maryland, and other institutions to advance animal biotechnology and improve livestock production systems.
